-
1
-
-
0023864355
-
Thrombolysis In Myocardial Infarction (TIMI) trial-phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase
-
Rao A.K., Pratt C., Berke A., Jaffe A., Ockene I., Schreiber T.L., Bell W.R., Knatterud G., Robertson T.L., and Terrin M.L. Thrombolysis In Myocardial Infarction (TIMI) trial-phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol 11 (1988) 1-11
-
(1988)
J Am Coll Cardiol
, vol.11
, pp. 1-11
-
-
Rao, A.K.1
Pratt, C.2
Berke, A.3
Jaffe, A.4
Ockene, I.5
Schreiber, T.L.6
Bell, W.R.7
Knatterud, G.8
Robertson, T.L.9
Terrin, M.L.10
-
2
-
-
0027240597
-
An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
-
The GUSTO Investigators
-
The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329 (1993) 673-682
-
(1993)
N Engl J Med
, vol.329
, pp. 673-682
-
-
-
3
-
-
33745960402
-
Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry
-
Spertus J.A., Kettelkamp R., Vance C., Decker C., Jones P.G., Rumsfeld J.S., Messenger J.C., Khanal S., Peterson E.D., Bach R.G., Krumholz H.M., and Cohen D.J. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 113 (2006) 2803-2809
-
(2006)
Circulation
, vol.113
, pp. 2803-2809
-
-
Spertus, J.A.1
Kettelkamp, R.2
Vance, C.3
Decker, C.4
Jones, P.G.5
Rumsfeld, J.S.6
Messenger, J.C.7
Khanal, S.8
Peterson, E.D.9
Bach, R.G.10
Krumholz, H.M.11
Cohen, D.J.12
-
4
-
-
33846102236
-
Assessment of bleeding events in clinical trials-proposal of a new classification
-
Serebruany V.L., and Atar D. Assessment of bleeding events in clinical trials-proposal of a new classification. Am J Cardiol 99 (2007) 288-290
-
(2007)
Am J Cardiol
, vol.99
, pp. 288-290
-
-
Serebruany, V.L.1
Atar, D.2
-
5
-
-
63749112292
-
Combination antiplatelet therapy for secondary stroke prevention: enhanced efficacy or double trouble?
-
Usman M.H., Notaro L.A., Nagarakanti R., Brahin E., Dessain S., Gracely E., and Ezekowitz M.D. Combination antiplatelet therapy for secondary stroke prevention: enhanced efficacy or double trouble?. Am J Cardiol 103 (2009) 1107-1112
-
(2009)
Am J Cardiol
, vol.103
, pp. 1107-1112
-
-
Usman, M.H.1
Notaro, L.A.2
Nagarakanti, R.3
Brahin, E.4
Dessain, S.5
Gracely, E.6
Ezekowitz, M.D.7
-
6
-
-
33646732608
-
Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease
-
Jernberg T., Payne C.D., Winters K.J., Darstein C., Brandt J.T., Jakubowski J.A., Naganuma H., Siegbahn A., and Wallentin L. Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease. Eur Heart J 27 (2006) 1166-1173
-
(2006)
Eur Heart J
, vol.27
, pp. 1166-1173
-
-
Jernberg, T.1
Payne, C.D.2
Winters, K.J.3
Darstein, C.4
Brandt, J.T.5
Jakubowski, J.A.6
Naganuma, H.7
Siegbahn, A.8
Wallentin, L.9
-
7
-
-
0141919739
-
Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study
-
Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) Trial Investigators
-
Peters R.J., Mehta S.R., Fox K.A., Zhao F., Lewis B.S., Kopecky S.L., Diaz R., Commerford P.J., Valentin V., Yusuf S., and Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) Trial Investigators. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study. Circulation 108 (2008) 1682-1687
-
(2008)
Circulation
, vol.108
, pp. 1682-1687
-
-
Peters, R.J.1
Mehta, S.R.2
Fox, K.A.3
Zhao, F.4
Lewis, B.S.5
Kopecky, S.L.6
Diaz, R.7
Commerford, P.J.8
Valentin, V.9
Yusuf, S.10
-
8
-
-
0037145863
-
Clopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial
-
CREDO Investigators
-
Steinhubl S.R., Berger P.B., Mann III J.T., Fry E.T., DeLago A., Wilmer C., Topol E.J., and CREDO Investigators. Clopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 288 (2002) 2411-2420
-
(2002)
JAMA
, vol.288
, pp. 2411-2420
-
-
Steinhubl, S.R.1
Berger, P.B.2
Mann III, J.T.3
Fry, E.T.4
DeLago, A.5
Wilmer, C.6
Topol, E.J.7
-
9
-
-
3242770664
-
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial
-
MATCH investigators
-
Diener H.C., Bogousslavsky J., Brass L.M., Cimminiello C., Csiba L., Kaste M., Leys D., Matias-Guiu J., Rupprecht H.J., and MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 364 (2004) 331-337
-
(2004)
Lancet
, vol.364
, pp. 331-337
-
-
Diener, H.C.1
Bogousslavsky, J.2
Brass, L.M.3
Cimminiello, C.4
Csiba, L.5
Kaste, M.6
Leys, D.7
Matias-Guiu, J.8
Rupprecht, H.J.9
-
10
-
-
33644876597
-
Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial
-
Clopidogrel as Adjunctive Reperfusion Therapy (CLARITY)-Thrombolysis In Myocardial Infarction (TIMI) 28 Investigators
-
Sabatine M.S., Morrow D.A., Montalescot G., Dellborg M., Leiva-Pons J.L., Keltai M., Murphy S.A., McCabe C.H., Gibson C.M., Cannon C.P., and Clopidogrel as Adjunctive Reperfusion Therapy (CLARITY)-Thrombolysis In Myocardial Infarction (TIMI) 28 Investigators. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial. Circulation 112 (2005) 3846-3854
-
(2005)
Circulation
, vol.112
, pp. 3846-3854
-
-
Sabatine, M.S.1
Morrow, D.A.2
Montalescot, G.3
Dellborg, M.4
Leiva-Pons, J.L.5
Keltai, M.6
Murphy, S.A.7
McCabe, C.H.8
Gibson, C.M.9
Cannon, C.P.10
-
11
-
-
57649084454
-
Impact of "nuisance" bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluting stent implantation
-
Roy P., Bonello L., Torguson R., de Labriolle A., Lemesle G., Slottow T.L., Steinberg D.H., Kaneshige K., Xue Z., Satler L.F., et al. Impact of "nuisance" bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluting stent implantation. Am J Cardiol 102 (2008) 1614-1617
-
(2008)
Am J Cardiol
, vol.102
, pp. 1614-1617
-
-
Roy, P.1
Bonello, L.2
Torguson, R.3
de Labriolle, A.4
Lemesle, G.5
Slottow, T.L.6
Steinberg, D.H.7
Kaneshige, K.8
Xue, Z.9
Satler, L.F.10
-
12
-
-
68649127826
-
-
Torguson R, Ben-Dor I, Kaneshige K, Pichard AD, Satler LF, Kent KM, Suddath WO, Waksman R. Incidence and correlates of nuisance bleeding following anti-platelet therapy for patients with drug eluting stents. (Abstract; Submitted to European Society of Cardiology (ESC) Congress 2009).
-
Torguson R, Ben-Dor I, Kaneshige K, Pichard AD, Satler LF, Kent KM, Suddath WO, Waksman R. Incidence and correlates of nuisance bleeding following anti-platelet therapy for patients with drug eluting stents. (Abstract; Submitted to European Society of Cardiology (ESC) Congress 2009).
-
-
-
-
13
-
-
17844373254
-
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents
-
Iakovou I., Schmidt T., Bonizzoni E., Ge L., Sangiorgi G.M., Stankovic G., Airoldi F., Chieffo A., Montorfano M., Carlino M., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
-
(2005)
JAMA
, vol.293
, pp. 2126-2130
-
-
Iakovou, I.1
Schmidt, T.2
Bonizzoni, E.3
Ge, L.4
Sangiorgi, G.M.5
Stankovic, G.6
Airoldi, F.7
Chieffo, A.8
Montorfano, M.9
Carlino, M.10
-
14
-
-
33645311266
-
Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents
-
Kuchulakanti P.K., Chu W.W., Torguson R., Ohlmann P., Rha S.W., Clavijo L.C., Kim S.W., Bui A., Gevorkian N., Xue Z., et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 113 (2006) 1108-1113
-
(2006)
Circulation
, vol.113
, pp. 1108-1113
-
-
Kuchulakanti, P.K.1
Chu, W.W.2
Torguson, R.3
Ohlmann, P.4
Rha, S.W.5
Clavijo, L.C.6
Kim, S.W.7
Bui, A.8
Gevorkian, N.9
Xue, Z.10
-
15
-
-
36148983750
-
Prasugrel versus clopidogrel in patients with acute coronary syndromes
-
TRITON-TIMI 38 Investigators
-
Wiviott S.D., Braunwald E., McCabe C.H., Montalescot G., Ruzyllo W., Gottlieb S., Neumann F.J., Ardissino D., De Servi S., Murphy S.A., et al., TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357 (2007) 2001-2015
-
(2007)
N Engl J Med
, vol.357
, pp. 2001-2015
-
-
Wiviott, S.D.1
Braunwald, E.2
McCabe, C.H.3
Montalescot, G.4
Ruzyllo, W.5
Gottlieb, S.6
Neumann, F.J.7
Ardissino, D.8
De Servi, S.9
Murphy, S.A.10
|